# Vir Biotechnology, Inc.: Form DEF 14A, filed Apr 17, 2025

- Company: [Vir Biotechnology, Inc.](/companies/vir.md) (CIK 1706431)
- Form: DEF 14A
- Filed: 2025-04-17
- Accepted by EDGAR: Apr 17, 2025, 08:33 ET
- Period: 2025-05-29
- Accession: 0001628280-25-018119
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1706431/000162828025018119/vir-20250417.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1706431/000162828025018119/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1706431/000162828025018119/vir-20250417.htm

Filed Apr 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-018119. Last ingested by Listed: Nov 4, 2026, 19:18 ET. No prices; not investment advice.
